RT Book, Section
A1 Li, Zhigang
A1 Rice, Thomas W.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105839260
T1 Salvage Surgery for Recurrent Esophageal Cancer
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105839260
RD 2024/04/23
AB Recurrent  (after  a  disease-free  period)  or  persistent  esophageal  cancer  following  definitive  therapy,  particularly  for  locally  advanced  cancer,  is  common.  Treatment  failure  following  definitive  chemoradiotherapy  in  RTOG-8501  was  46%  at  a  minimum  of  5  years  follow-up.1  Twenty  percent  of  patients  had  recurrence  after  clinical  complete  response  and  26%  persistent  cancer.  In  RTOG-8911  following  R0  esophagectomy,  at  a  median  follow-up  of  8.8  years,  cancer  recurrence  was  reported  in  52%  of  patients  receiving  induction  chemotherapy  and  56%  of  patients  with  esophagectomy  alone.2